Hepatocellular Carcinoma: Current Management and Future Development
Author Information
Author(s): Kishi Yoji, Hasegawa Kiyoshi, Sugawara Yasuhiko, Kokudo Norihiro
Primary Institution: Graduate School of Medicine, The University of Tokyo
Hypothesis
Surgical resection is the treatment strategy offering the best long-term outcomes in patients with hepatocellular carcinoma (HCC).
Conclusion
Surgical resection remains the best option for long-term outcomes in HCC patients, but high recurrence rates necessitate multimodal approaches.
Supporting Evidence
- Surgical resection is the only potentially curative treatment for advanced HCC.
- Minimally invasive laparoscopic hepatectomy has become popular but requires further evaluation of long-term outcomes.
- Multimodal approaches may improve prognosis for patients with recurrent HCC.
Takeaway
Doctors can help people with liver cancer by removing the tumor through surgery, which works best for long-term health, but sometimes the cancer comes back.
Methodology
The paper reviews current management strategies for HCC, focusing on surgical resection and multimodal treatments.
Potential Biases
Selection bias may affect the outcomes reported in retrospective studies.
Limitations
Most studies referenced are retrospective, which may introduce bias.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website